Updates

CSRxP Praises Administration For Implementing Direct-To-Consumer Advertising Rule

May 8, 2019

Greater List Price Transparency Will Help Hold Big Pharma Accountable  Read More

CSRxP: Senate Judiciary Lawmakers Grill Big Pharma, Demonstrate Bipartisan Commitment To Action

May 7, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Welcomes Senate Scrutiny Of Big Pharma’s Patent Abuse

May 6, 2019

Encourages Judiciary Committee To Hold Drug Makers Accountable Read More

CBO Confirms: Rebate Rule Comes At Tremendous Cost to Seniors And Taxpayers

May 2, 2019

Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That Read More

Q1 Earnings Show Big Pharma Booming While American Patients Struggle

May 1, 2019

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Read More

Big Pharma Earnings Watch

May 1, 2019

GSK Completes The Sweep: Joins Fellow Drug Maker Giants In Beating Q1 Profit Read More

Q1 EARNINGS SHOW BIG PHARMA BOOMING WHILE AMERICAN PATIENTS STRUGGLE

May 1, 2019

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Read More

Big Pharma Earnings Watch: Three More Pharma Giants Top Earnings Forecasts, Raise Outlooks

Apr 30, 2019

Three more earnings reports from drug makers show Big Pharma is doing just Read More

CSRxP Applauds Advancement Of Bipartisan CREATES Act

Apr 30, 2019

Praises Lawmakers For Commitment To Delivering Relief For Patients Washington, Read More

CSRxP Applauds Continued Drug Price Activity & Momentum On Capitol Hill

Apr 29, 2019

Encourages House Judiciary Committee To Advance Bipartisan CREATES Act Read More

Big Pharma Earnings Watch

Apr 27, 2019

Big Pharma Flying High: Sanofi & AstraZeneca Beat First Quarter Profit Read More

Big Pharma Earnings Watch: Bristol-Myers Squibb

Apr 26, 2019

Trend Emerges: Bristol-Myers Squibb Joins Big Pharma Colleagues Beating First Read More